Israel Englander Milestone Pharmaceuticals Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 322,082 shares of MIST stock, worth $383,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

322,082

Previous 2,703,259 88.09%

Holding current value

$383,277

Previous $6.38 Million 95.97%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.8 - $2.41 $1.9 Million - $5.74 Million	-2,381,177 Reduced 88.09%	322,082 $257,000
Q4 2024 Feb 14, 2025	SELL	$1.43 - $2.36 $107,630 - $177,627	-75,266 Reduced 2.71%	2,703,259 $6.38 Million
Q3 2024 Nov 14, 2024	BUY	$1.29 - $1.65 $36,887 - $47,181	28,595 Added 1.04%	2,778,525 $4.22 Million
Q2 2024 Aug 14, 2024	SELL	$1.29 - $1.83 $136,329 - $193,398	-105,682 Reduced 3.7%	2,749,930 $3.63 Million
Q1 2024 May 15, 2024	BUY	$1.4 - $2.2 $1.91 Million - $2.99 Million	1,361,123 Added 91.08%	2,855,612 $5.11 Million
Q4 2023 Feb 14, 2024	SELL	$1.67 - $3.39 $428,653 - $870,141	-256,679 Reduced 14.66%	1,494,489 $2.5 Million
Q2 2023 Aug 14, 2023	BUY	$2.85 - $4.4 $63,116 - $97,442	22,146 Added 1.28%	1,751,168 $4.99 Million
Q1 2023 May 15, 2023	SELL	$3.14 - $4.2 $835,261 - $1.12 Million	-266,007 Reduced 13.33%	1,729,022 $6.81 Million
Q4 2022 Feb 14, 2023	BUY	$3.53 - $9.5 $3.75 Million - $10.1 Million	1,061,931 Added 113.81%	1,995,029 $7.9 Million
Q3 2022 Nov 14, 2022	SELL	$5.86 - $9.43 $2.49 Million - $4.01 Million	-425,264 Reduced 31.31%	933,098 $8.58 Million
Q2 2022 Aug 15, 2022	BUY	$5.13 - $7.37 $356,222 - $511,765	69,439 Added 5.39%	1,358,362 $8.07 Million
Q1 2022 May 16, 2022	BUY	$4.1 - $8.24 $1.24 Million - $2.5 Million	303,056 Added 30.74%	1,288,923 $8.28 Million
Q4 2021 Feb 14, 2022	BUY	$5.47 - $7.13 $1.59 Million - $2.07 Million	290,626 Added 41.8%	985,867 $6.46 Million
Q3 2021 Nov 15, 2021	SELL	$5.28 - $6.29 $123,493 - $147,116	-23,389 Reduced 3.25%	695,241 $3.97 Million
Q2 2021 Aug 16, 2021	BUY	$5.22 - $6.11 $4,348 - $5,089	833 Added 0.12%	718,630 $3.95 Million
Q1 2021 May 17, 2021	BUY	$5.79 - $8.85 $11,643 - $17,797	2,011 Added 0.28%	717,797 $4.16 Million
Q4 2020 Feb 16, 2021	BUY	$5.57 - $7.66 $2.27 Million - $3.13 Million	408,032 Added 132.58%	715,786 $4.8 Million
Q3 2020 Nov 16, 2020	BUY	$3.34 - $9.8 $1.03 Million - $3.02 Million	307,754 New	307,754 $2.25 Million
Q2 2020 Aug 14, 2020	SELL	$1.77 - $4.56 $339,588 - $874,872	-191,858 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.7 - $22.5 $276,018 - $3.65 Million	162,364 Added 550.5%	191,858 $353,000
Q4 2019 Feb 14, 2020	BUY	$15.4 - $21.9 $89,166 - $126,800	5,790 Added 24.43%	29,494 $472,000
Q3 2019 Nov 14, 2019	SELL	$15.67 - $25.96 $164,456 - $272,450	-10,495 Reduced 30.69%	23,704 $410,000
Q2 2019 Aug 15, 2019	BUY	$15.37 - $27.15 $318,927 - $563,362	20,750 Added 154.29%	34,199 $929,000
Q2 2019 Aug 14, 2019	BUY	$15.37 - $27.15 $206,711 - $365,140	13,449 New	13,449 $292,000

Others Institutions Holding MIST

# of Institutions

Shares Held

16.8M

Call Options Held

341K

Put Options Held

70.3K

View Full List

About Milestone Pharmaceuticals Inc.

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $35.7M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

More about MIST

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account